🇺🇸 FDA
Patent

US 10619156

Hybrid tRNA/pre-miRNA molecules and methods of use

granted A61PA61P35/00A61P35/02

Quick answer

US patent 10619156 (Hybrid tRNA/pre-miRNA molecules and methods of use) held by The Regents of the University of California expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00, A61P35/02